论文部分内容阅读
目的观察米非司酮和天花粉治疗异位妊娠的疗效。方法将确诊为异位妊娠行药物保守治疗的60例患者分为米非司酮组和天花粉组,分别观察两组疗效、不良反应、住院天数、住院费用及其绒毛膜促性腺激素β-HCG值与疗效的关系。结果米非司酮组和天花粉组治疗异位妊娠的疗效、住院天数、住院费用均相当(P>0.05),但天花粉组不良反应显著高于米非司酮组(P<0.05),β-HCG>1000U/L治愈率明显低于β-HCG<1000U/L(P<0.05)。结论米非司酮治疗异位妊娠服用方便、不良反应轻且少,是药物保守治疗异位妊娠安全可靠的药物,值得推广。
Objective To observe the efficacy of mifepristone and TCS in the treatment of ectopic pregnancy. Methods Sixty patients with conservative treatment of ectopic pregnancy were divided into mifepristone group and TCS group. The curative effects, adverse reactions, days of hospitalization, hospitalization cost and their chorionic gonadotropin β-HCG The relationship between value and efficacy. Results The efficacy, duration of hospitalization and hospitalization of mifepristone group and TCS group for ectopic pregnancy were similar (P> 0.05), but adverse reactions in TC group were significantly higher than those in mifepristone group (P <0.05) The cure rate of HCG> 1000U / L was significantly lower than that of β-HCG <1000U / L (P <0.05). Conclusions Mifepristone has the advantages of convenience in taking ectopic pregnancy, less and less adverse reactions, and is a safe and reliable medicine for the conservative treatment of ectopic pregnancy. It is worth promoting.